Newsroom

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

We leave the lab to find out what people know about cell and gene therapy.

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Cynthia lives with Heart Failure with preserved Ejection Fraction, a complex and challenging condition.

Kazani describes how her flexible work arrangement helps her balance her personal and professional lives.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Karpiak explains how her flexible schedule enables her to succeed at work while staying active in her community.